IVVD - Invivyd Inc Price/Earnings to Growth Ratio

Invivyd, Inc. (IVVD) develops advanced antiviral antibodies, although the brand's success depends on regulatory approvals and the speed of combating mutations. The PEG ratio allows these risks to be weighed against the market price, where 0.00 captures the current state of the parameter. The company is currently scaling sales of its drugs by expanding its network of hospital partnerships to protect patients.

Invivyd Inc (IVVD): Price/Earnings to Growth Ratio from 04/28/2023 to 11/10/2026

Metric breakdowns and analytics for Invivyd, Inc. (IVVD)

- share price and consensus valuation forecast:

Price Performance Chart invivyd.com|IVVD - Consensus Target

- market capitalization statistics:

Market Value Invivyd Corp|IVVD - Enterprise Value

- issuer book value statistics:

Net Assets per Share Invivyd, Inc.|IVVD - Company Book Value|Market Value to Book Value invivyd.com|IVVD - Cumulative Company Assets

- debt obligations and liquidity statistics:

- net income and valuation ratios data:

IVVD - Net Profit|Company Profit Forecast Invivyd, Inc.|IVVD - Price to Earnings Ratio|Future Price to Earnings invivyd.com|IVVD - Price/Earnings to Growth Multiple|Company Value to EBITDA Invivyd Corp|IVVD - Operating profit EBITDA|Earnings per share for the last 12 months Invivyd, Inc.|IVVD - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months invivyd.com|IVVD - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Invivyd, Inc.

General company analysis:IVVD, Invivyd Inc

The PEG ratio compares the current market earnings multiple with the rate of earnings growth, identifying assets whose valuation lags behind their development dynamics. By analyzing the business undervaluation factor via PEG, an investor assesses the capitalization efficiency of innovations at Invivyd, Inc. (IVVD), where strategic partnerships in evolving antibodies accelerate drug commercialization, creating a foundation for outpaced earnings growth.

Competitors of Invivyd, Inc.